Liquidia Corporation

NasdaqCM:LQDA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

Location

United States

Market Cap

USD 1.13 B

Share Price

USD 13.26

Avg Daily Volume

1,539,774

Change (1 day)

0.68%

Change (1 year)

8.69%

Change (YTD)

12.75%

Liquidia Corporation Market Capitalization on June 23, 2025: USD 1.13 B

Liquidia Corporation Market Capitalization is USD 1.13 B on June 23, 2025, a 14.03% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Liquidia Corporation 52-week low Market Capitalization is USD 1.67 B on June 23, 2025, which is 47.22% above the current Market Capitalization.
Liquidia Corporation 52-week low Market Capitalization is USD 735.17 M on June 23, 2025, which is -35.14% below the current Market Capitalization.
Liquidia Corporation average Market Capitalization for the last 52 weeks is USD 1.07 B.

Daily

From:

To:

Zoom:

3M
6M
YTD
1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

NasdaqCM: LQDA

Liquidia Corporation

CEO	Dr. Roger A. Jeffs Ph.D.
IPO Date	July 26, 2018
Location	United States
Headquarters	419 Davis Drive
Employees	170
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💊 Drugstores & Retail Pharmacies 💊 Pharmaceuticals

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Similar companies

Eli Lilly and Company

USD 770.64

1.04%

AbbVie Inc.

USD 183.76

-0.83%

Roche Holding AG

USD 339.66

0.85%

AstraZeneca PLC

USD 140.89

0.81%

Merck & Co., Inc.

USD 80.16

1.39%

Amgen Inc.

USD 272.44

-5.84%

Pfizer Inc.

USD 24.03

0.25%

Gilead Sciences, Inc.

USD 106.19

-2.13%

Sanofi

USD 96.16

0.29%

Bristol-Myers Squibb Company

USD 46.92

0.13%

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

GSK plc

USD 18.97

0.58%

Cencora, Inc.

USD 293.13

-0.18%

Regeneron Pharmaceuticals, Inc.

USD 511.92

0.43%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

0.15%

Haleon plc

USD 5.19

0.41%

Takeda Pharmaceutical Company Limited

USD 29.87

1.96%

Daiichi Sankyo Company, Limited

USD 23.15

2.56%

UCB SA

USD 190.31

4.88%

Hansoh Pharmaceutical Group Company Limited

USD 3.73

2.31%

Teva Pharmaceutical Industries Limited

USD 17.10

-0.70%

Insmed Incorporated

USD 105.42

2.67%

West Pharmaceutical Services, Inc.

USD 216.70

0.41%

Summit Therapeutics Inc.

USD 20.39

-0.83%

Cipla Limited

USD 17.50

0.80%

United Therapeutics Corporation

USD 286.39

-1.50%

Dr. Reddy's Laboratories Limited

USD 15.44

1.18%

Torrent Pharmaceuticals Limited

USD 36.76

0.26%

Sino Biopharmaceutical Limited

USD 0.67

1.78%

Zydus Lifesciences Limited

USD 11.12

0.85%

CSPC Pharmaceutical Group Limited

USD 1.01

3.28%

Mankind Pharma Limited

USD 26.77

0.47%

Ascendis Pharma A/S

USD 175.78

-0.63%

BioMarin Pharmaceutical Inc.

USD 54.08

-1.67%

Viatris Inc.

USD 8.85

-0.22%

Orion Oyj

USD 73.97

1.03%

Lupin Limited

USD 22.60

1.25%

Huadong Medicine Co., Ltd

USD 5.55

-4.21%

Ipsen S.A.

USD 116.69

0.38%

Swedish Orphan Biovitrum AB (publ)

USD 28.73

1.93%

Kyowa Kirin Co., Ltd.

USD 17.15

1.10%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.06

1.80%

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.50

1.42%

Abbott India Limited

USD 362.33

0.75%

Eisai Co., Ltd.

USD 27.34

1.19%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.82

1.55%

Sinopharm Group Co. Ltd.

USD 2.38

1.23%

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 6.71

2.40%

Beijing Tongrentang Co., Ltd

USD 5.01

-0.21%

Haisco Pharmaceutical Group Co., Ltd.

USD 5.95

4.00%

StockViz Staff

June 24, 2025

Any question? Send us an email